Oragenics Inc. (OGEN)

0.47
0.01 1.50
AMEX : Health Technology
Prev Close 0.48
Open 0.48
Day Low/High 0.47 / 0.48
52 Wk Low/High 0.38 / 3.74
Volume 309.45K
Avg Volume 1.20M
Exchange AMEX
Shares Outstanding 46.12M
Market Cap 21.94M
EPS -0.90
P/E Ratio N/A
Div & Yield N.A. (N.A)
3 Health Care Stocks Pushing The Sector Higher

3 Health Care Stocks Pushing The Sector Higher

TheStreet highlights 3 stocks that pushed the Health Care sector

Oragenics Advances Towards Identification Of Lead Antibiotic Clinical Candidate

Oragenics Advances Towards Identification Of Lead Antibiotic Clinical Candidate

Oragenics, Inc. (NYSE MKT: OGEN) announced today that through its Exclusive Channel Collaboration (ECC) with Intrexon Corporation (NYSE: XON), a leader in synthetic biology, it has produced and analyzed a...

Oragenics Appoints Al Fosmoe As Senior Vice President Of Operations/Product Development

Oragenics Appoints Al Fosmoe As Senior Vice President Of Operations/Product Development

Oragenics, Inc. (NYSE:MKT - OGEN), a leader in the development of novel, effective antibiotics and oral care probiotics, today announced that Mr.

Oragenics To Present At Biotech Showcase 2014

Oragenics To Present At Biotech Showcase 2014

Oragenics, Inc. (NYSE:MKT - OGEN), a leader in the development of novel, effective antibiotics and oral care probiotics, today announced that Dr.

Oragenics, Inc. States That Its Policy Is Not To Comment On Unusual Market Activity

Oragenics, Inc. States That Its Policy Is Not To Comment On Unusual Market Activity

Oragenics, Inc. (NYSE MKT:OGEN) (the “Company”) today announced that in view of the unusual market activity in the Company’s stock, the NYSE MKT (the “Exchange”) has contacted the Company...

Top Insider Trades: OGEN, FOLD, ACHN, ZINC

Top Insider Trades: OGEN, FOLD, ACHN, ZINC

The top 10 open-market insider purchases and sales filed at the SEC Friday.

Oragenics Announces Completion Of Public Offering Of Common Stock

Oragenics Announces Completion Of Public Offering Of Common Stock

Oragenics, Inc. (NYSE MKT: OGEN) (the “Company”) announced today that it has completed its previously announced underwritten public offering of 4,400,000 shares of common stock at a public offering price...

Oragenics Prices Public Offering Of Common Stock

Oragenics Prices Public Offering Of Common Stock

Oragenics, Inc. (NYSE MKT: OGEN) (the “Company”) announced today that it has priced an underwritten public offering of 4,400,000 shares of its common stock at a public offering price of $2.

Oragenics Announces Proposed Public Offering Of Common Stock

Oragenics Announces Proposed Public Offering Of Common Stock

Oragenics, Inc. (NYSE MKT: OGEN) today announced its intention to offer and sell shares of its common stock in an underwritten public offering pursuant to its existing shelf registration statement.

Oragenics Announces Breakthrough Antibiotic Analog Generation In Intrexon Collaboration

Oragenics Announces Breakthrough Antibiotic Analog Generation In Intrexon Collaboration

Oragenics, Inc. (NYSE MKT: OGEN) announced today that through its Exclusive Channel Collaboration (ECC) with Intrexon Corporation (NYSE:XON), a leader in synthetic biology, it has successfully engineered a...

Top Insider Trades: ACHN PARR OPHT OGEN

Top Insider Trades: ACHN PARR OPHT OGEN

The top 10 open-market insider purchases and sales filed at the SEC Wednesday.

Oragenics Collaboration Demonstrates Initial Success In The Second Phase Of Lantibiotics Project

Oragenics Collaboration Demonstrates Initial Success In The Second Phase Of Lantibiotics Project

Oragenics, Inc. (NYSE MKT: OGEN) announced today that through its Exclusive Channel Collaboration (ECC) with Intrexon Corporation (NYSE:XON), a synthetic biology company, preliminary experiments demonstrate...

Oragenics To Join The Russell Microcap® Index

Oragenics To Join The Russell Microcap® Index

Oragenics, Inc. (NYSE MKT:OGEN), a healthcare company focused on becoming the world leader in novel antibiotics against infectious disease and probiotcs for oral health, announced today that it will be included in the...

Oragenics Receives First European Patent For ProBiora3® Probiotic Blend

Oragenics Receives First European Patent For ProBiora3® Probiotic Blend

Oragenics, Inc. (OTCQB: OGEN)(OTCBB: OGEN) today announced it has received its first patent approval in Europe for its ProBiora3® products.

Oragenics-Intrexon Collaboration Announces Significant Progress Towards Commercial Production Of Lead Lantibiotic MU1140

Oragenics-Intrexon Collaboration Announces Significant Progress Towards Commercial Production Of Lead Lantibiotic MU1140

Oragenics, Inc. (OTCBB: OGEN) announced today that its Exclusive Channel Collaboration (ECC) with Intrexon Corporation, a synthetic biology company, has produced an exponential increase in the fermentation...

Oragenics Receives European Union CPNP Notifications For ProBiora3® Cosmetic Tablets

Oragenics Receives European Union CPNP Notifications For ProBiora3® Cosmetic Tablets

Oragenics, Inc. (OTCQB: OGEN) (OTCBB: OGEN), today announced its ProBiora3® tablets intended to freshen breath, whiten teeth and contribute to overall oral health has successfully completed an independent third ...

John N. Bonfiglio, PhD President And CEO Oragenics, Inc. (Photo: Business Wire)

John N. Bonfiglio, PhD President And CEO Oragenics, Inc. (Photo: Business Wire)

Oragenics, Inc. (OTCQB:OGEN) (OTCBB: OGEN), today announced Dr.

Oragenics Announces New Strategic Partnership With Japanese-Based Company, Organic Wave, Inc. Dba KYB America

Oragenics Announces New Strategic Partnership With Japanese-Based Company, Organic Wave, Inc. Dba KYB America

Oragenics, Inc. (OTCQB: OGEN) (OTCBB: OGEN) (the “Company”), a world leader in oral care probiotics, today announced that the Company has entered into a new three year contract agreement with Organic Wave,...

John N. Bonfiglio, PhD President And CEO Oragenics, Inc. (Photo: Business Wire)

John N. Bonfiglio, PhD President And CEO Oragenics, Inc. (Photo: Business Wire)

Oragenics, Inc. (OTCQB:OGEN) (OTCBB:OGEN), today announced Dr.